09:59 AM EST - Bausch Health Companies Inc. : Issued the following statement in response to a request from the Canadian Investment Regulatory Organization. "As previously disclosed, the Company believes that completing the full separation of its subsidiary, Bausch + Lomb Corporation makes strategic sense. The Bausch Health Board of Directors authorized management and management of its subsidiary, Bausch + Lomb, to explore a potential sale, which is one of several options being considered to complete the separation. Bausch Health Companies Inc.
shares T.BHC are trading up $0.06 at $10.79.
